1.25 hours with Assessment – Optometry Australia IoE Quality Assurance | 0.5G in New Zealand
Aberrant complement activation, which is affected by a number of genetic and environmental risk factors, appears to play a significant role in the progression of age-related macular degeneration (AMD). Current and emerging therapeutic strategies to manipulate these overactive complement pathways have potential to slow the progression of geographic atrophy in AMD and, in doing so, save sight…Read and take test.
